A sedentary lifestyle, unhealthy eating
habits, and growing stress levels are increasingly responsible for
severe hair loss and damage, also known as alopecia. Ageing, hormonal
imbalance, and increasing prevalence of cancer, arthritis, hypertension,
and depression are other factors causing alopecia. Thus, the alopecia
treatment market is anticipated to witness significant growth in the
coming years owing to a surge in the prevalence of alopecia. The number
of people seeking alopecia treatment is extremely high in developed
nations. However, increased healthcare expenditure has spurred the
demand for alopecia treatment in developing nations such as China and
India as well.
The alopecia treatment market is
segmented on the basis of product, gender, end user, and geography. By
product, the market is segmented into shampoos and conditioners,
vitamins and supplements, and other (gels, oils, and serums). On the
basis of end user, the market is segmented into homecare settings,
dermatology clinics, and others.
The report covers an exhaustive analysis
on the alopecia treatment market segments, including the leading,
declining, and fastest growing segments. It comprises the analysis of
market dynamics, the market size and forecast, and the trends, threats,
and opportunities. The study also comprises the vendor landscape, degree
of competition, threat of new entrants, and the bargaining power of
buyers and suppliers.
Overview of the Alopecia Treatment Market
According to the American Hair Loss
Association, 95% of the hair loss in men is caused by androgenetic
alopecia. The Association also states Moreover, the body also states
that around 800 thousand people are undergoing some form of treatment
for hair loss across the globe. The rise in the geriatric population and
increasing hypertension and depression among the middle aged population
are some of the factors driving the alopecia treatment market. A
growing demand for surgical hair transplant is expected to drive the
global alopecia treatment market in the coming years. An increase in the
disposable income of the people, technological advancements in hair
treatment medical devices, and a growing emphasis on looking good are
some of the other factors driving the market. Moreover, the easy
accessibility to scalp treatment is also helping the market to grow.
The global alopecia treatment market is
expected to be restricted by the high cost of medications. The probable
side effects, reactions, and allergies caused by alopecia treatments
will further hamper the growth of the market. Decreased libido, high BP,
increase in the heart rate, and erectile dysfunction are some of the
side effects caused by alopecia treatment, threatening the market’s
growth. However, technological advancements and the development of novel
therapeutic drugs are expected to bring new opportunities for growth in
the market.
On the basis of geography, the global
alopecia treatment market is segmented into Europe, Asia Pacific, North
America, and the Rest of the World, of which North America is currently
the largest segment. North America is also the most significant revenue
generator at present, owing to the rise in hair loss among people and
the high treatment rates. The high disposable income of the people and
the availability of innovative therapeutic solutions are also factors
driving the growth of the market in North America.
Companies Mentioned in the Report
The report profiles leading players in
the global alopecia treatment market. Important information pertaining
to players, such as their recent developments, product picture,
specifications, and price, and the challenges faced by them are
included. Additionally, the report covers strategies adopted by key
players to grow in the alopecia treatment market. The key vendors
include Vitabiotics, Sun Pharma, Merck & Co., Alpecin, Dr. Reddy’s
Laboratories, Cipla, Johnson & Johnson, Kirkland Signature, Phyto
Ales Group, and Lifes2good.
No comments:
Post a Comment